We went on to verify whether the GABRB3 gene, which showed significant associations with OS in GBM patients from the French cohort and also for TCGA-LGG patients when all tumor types were pooled together, would show influences on OS when lower grade tumors are analyzed separately. This evidence concerns the gene GABRB3 and neoplasm.